In summary, through bioinformatics and in vitro assays, this study demonstrated that BAP1 was a tumor suppressor in osteosarcoma and provided new clues for osteosarcoma treatment such as BAP1-targeted therapy. This evidence concerns the gene BAP1 and osteosarcoma.